An allergy or Type I hypersensitivity is a immune malfunction whereby a person's body is hypersensitised to react immunologically to typically nonimmunogenic substances. When a person is hypersensitised these substances are known as allergens. The word allergy derives from the Greek words allos meaning "other" and ergon meaning "reaction" or "reactivity". Type I hypersensitivity is characterised by excessive activation of mast cells by immunoglobulin E resulting in a systemic inflammatory response that can result in symptoms as benign as a runny nose, to life-threatening anaphylactic shock and death.Signs and symptoms of allergies
Allergy is characterised by a local or systemic inflammatory response to allergens. Local symptoms are:
Systemic allergic response is also called anaphylaxis. Depending of the rate of severity, it can cause cutaneous reactions, bronchoconstriction, oedema, hypotension, coma and even death.
Hay fever is one example of an exceedingly common minor allergy - large percentages of the population suffer from hayfever symptoms in response to airborne pollen. Asthmatics are often allergic to dust mites. Apart from ambient allergens, allergic reactions can be due to medications.Diagnosis of Allergies
There are several methods for the diagnosis and assessment of allergies.Skin Test
The typical and most simple method of diagnosis and monitoring of Type I Hypersensitivity is by skin testing, also known as prick testing, due to the series of pricks made into the patients skin. Small amounts of suspected allergens and/or their extracts (pollen, grass, mite proteins, peanut extract etc.) are introduced to sites on the skin marked with pen or dye (it must be noted that ink/dye should be carefully selected, lest it cause an allergic response itself). The allergens are either injected intradermally or into small scratchings made into the patient's skin, often with a lancet. Common areas for testing include the inside forearm and back. If the patient is allergic to the substance then a visible inflammatory reaction will usually occur within 30 minutes. This response will range from slight reddening of the skin to full-blown hives in extremely sensitive patients.
After performing the skin test and receiving results, the doctor may apply a steroid cream to the test area to reduce discomfort (such as itching and inflammation).
Problems with skin test
In addition, the application of previously unencountered allergens can actually sensitize certain individuals to the allergen; that is, cause the inception of a new allergy in susceptible individuals.Total IgE count
Another method used to qualify type I hypersensitivity is measuring the amount of serum IgE contained within the patient's serum. This can be determined through the use of radiometric and colormetric immunoassays. Even the levels the amount of IgE specific to certain allergens can be measured through use of the radioallergosorbent test (RAST).Treatment of allergies
There are limited mainstream medical treatments for allergies, probably the most important factor in rehabilitation is the removal of sources of allergens from the home environment, and avoiding environments in which contact with allergens is likely. This can range from losing the family pets to primary schools having a strict no-peanut policy to protect a sensitive pupil.Immunotherapy and allergies
Hyposensitization is a form of immunotherapy where the patient is gradually vaccinated against progressively larger doses of the allergen in question. This can either reduce the severity or eliminate hypersensitivity altogether. It relies on the progressive skewing of IgG ("the blocking antibody") production, as opposed to the excessive IgE production seen in hypersensitivity type I cases.
In the 1960s, Dr. Len McEwen in the United Kingdom developed a treatment for allergies known as enzyme potentiated desensitization, or EPD. EPD uses much lower doses of antigens than conventional treatment, with the addition of an enzyme. EPD is available in the United Kingdom and Canada, and was available in the United States until 2001, when the Food and Drug Administration revoked its approval for an investigative study being performed. Since that time an American counterpart to EPD, known as Low Dose Antigens, or LDA, has been formulated from components approved by the FDA, and is available for treatment from a small number of doctors in the United States. EPD (and LDA) is still considered experimental by many mainstream doctors and medical insurance companies, and many doubt that it is more effective than a placebo.
A third form of immunotherapy involves the intravenous injection of monoclonal anti-IgE antibodies. These bind to free and B-cell IgE signalling such sources for destruction. They do not bind to IgE already bound to the Fc receptor on basophils and mast cells as this would stimulate the allergic inflammatory response.Chemotherapy and allergies
Several antagonistic drugs are used to block the action of allergic mediators, preventing activation of cells and degranulation processes. They include antihistamines, cortisone, adrenalin (epinephrine), theophylline and Cromolyn sodium. These drugs help alleviate the symptoms of allergy but play little role in chronic alleviation of the disorder. They can play an imperative role in the acute recovery of someone suffering from anaphylaxis (which is why those allergic to bee stings often carry an adrenalin needle with them at all times).Alternative therapies for allergies
In alternative medicine, a number of treatment modalities are considered effective by its practitioners in the treatment of allergies, particularly traditional Chinese medicine. However, none of these have been backed up by good quality evidence. On the contrary, they are generally criticised by mainstream medical researchers to be supported only by anecdotes, which makes them effective only as placebos. Dr. Andrew Weil, among others, believes that some allergies can be treated as though they were a psychosomatic illness.History of allergies
The term and concept of "allergy" were coined by a Viennese pediatrician named Baron Clemens von Pirquet in 1906. He observed that the symptoms of some of his patients might have been a response to outside allergens such as dust, pollen, or certain foods. For a long time all hypersensitivities were thought to stem from the improper action of inflammatory immunoglobulin class IgE, however it soon became clear that several different mechanisms utilizing different effector molecules were responsible for the myriad of disorders previously classified as "allergies". A new four-class (now five) classification scheme was designed by P. G. H. Gell and R. R. A. Coombs. Allergy has since been kept as the name for Type I Hypersensitivity, characterised by classical IgE mediation of effects.Pathophysiology
All hypersensitivities result from an aberration somewhere in the normal immune process. However the exact cause of such malfunctions are not always been apparent, and several arguments from genetic-basis, environmental-basis and intermediate proponents exist with varying validity and acceptance.Acute response
The difference between a type I hypersensitivity reaction against an allergen to the normal humoral response against a foreign body is that plasma cells secrete IgE as opposed to either IgM (against novel antigens) or IgG (against immunized antigens). IgE binds to Fc receptors on the surface of mast cells and basophils, both involved in the acute inflammatory response.
When IgE is first secreted it binds to the Fc receptors on a mast cell or basophil, and such a IgE-coated cell is said to sensitized to the allergen in question. A later exposure by the same allergen causes reactivation of these IgE, which then signal for the degranulation of the sensitized mast cell or basophil. These granules release histamine and other inflammatory chemical mediators (cytokines, interleukins, leukotrienes, and prostaglandins) into the surrounding tissue causing several systemic effects, such as vasodilation, mucous secretion, nerve stimulation and smooth muscle contraction. This results in the previously described symptoms of rhinorrhea, itchiness, dyspnea, and anaphylaxis. Depending on the individual, allergen, and mode of introduction, the symptoms can be system-wide (calliscal anaphylaxis), or localised to particular body systems (for example, asthma to the respiratory system; eczema to the dermis).Late-phase response
After the chemical mediators of the acute response subside, late phase responses can often occur. This is due to the migration of other leukocytes such as neutrophils, lymphocytes, eosinophils and macrophages to the initial site. The reaction is usually seen 4-6 hours after the original reaction and can last from 1-2 days. Cytokines from mast cells may also play a role in the persitence of long-term effects. Late phase responses seen in asthma are slightly different to those seen in other allergic responses.Genetic basis
There is much evidence to support the genetic basis of allergy, as allergic parents are more likely to have allergic children, and their allergies are likely to be stronger than those from non-allergic parents. However some allergies are not consistent along genealogies with parents being allergic to peanuts, but having children allergic to ragweed, or siblings not sharing the same allergens.made on the basis of the stage.
Disclaimer: Information shared in this section is indicative. Please do not make any conclusion and we strongly recommend you to consult with your Doctor. Symptoms may vary with individual, geography, climate and lifestyle